ArticleThe Journal of clinical investigation2021

Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacy.

Marina Baretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.